2021 annual financial data
ADC Therapeutics 2021 Operating cash flow
Direct answer
Operating cash flow was -233,378,000 USD.
Operating income was -261,720,000 USD and net income was -230,026,000 USD.
Operating cash flow was -233,378,000 USD.
Get free ADC Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 33,917,000 USD
- Operating income
- -261,720,000 USD
- Net income
- -230,026,000 USD
- Operating cash flow
- -233,378,000 USD